Metabolic Syndrome in Healthy Obese, Overweight, and Normal Weight Individuals: The Atherosclerosis Risk in Communities Study

被引:94
作者
Bradshaw, Patrick T. [1 ,2 ]
Monda, Keri L. [1 ,3 ]
Stevens, June [1 ,2 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA
[3] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA
关键词
INSULIN-RESISTANCE SYNDROME; BODY-MASS INDEX; PROVISIONAL REPORT; PHYSICAL-ACTIVITY; US POPULATION; PREVALENCE; DEFINITION; EXERCISE; DISEASE; QUESTIONNAIRE;
D O I
10.1002/oby.20248
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: There is recent interest in characterizing the subset of obese (OB) individuals who have healthy metabolic profiles yet only two studies have examined this group prospectively but not in racially diverse populations. Design and Methods: We analyzed factors associated with the prevalence and incidence of metabolic syndrome (MetSyn) among individuals grouped by BMI categories in a multi-center, community-based cohort of 14,663 African-American and white men and women aged 45-64 years at recruitment in 1987-1989, the Atherosclerosis Risk in Communities (ARIC) Study. Logistic and proportional hazards regression were utilized to estimate odds ratios (ORs) for the prevalence and hazard ratios (HRs) for incidence of MetSyn with 95% confidence intervals (CIs). Results: At visit 1, MetSyn was positively associated with age, female gender, African-American race, and inversely related to education, associations being more pronounced among normal weight (NW) subjects. Among those without MetSyn at visit 1, OB subjects were more likely to develop MetSyn compared with NW (HR (95% CI): 4.53 (4.09-5.01)). Several factors were associated with incident MetSyn among NW, including older age (per year: 1.05 (1.03-1.06)), female gender (vs. male: 1.29 (1.10-1.52)), heavy alcohol intake (vs. never: 0.75 (0.59-0.94)), and physical activity (tertile 3 vs. tertile 1: 0.71 (0.58-0.86)) but not OB. Weight gain (>5%) was also more highly associated with MetSyn in NW (1.61 (1.28-2.02)) compared with OB (1.01 (0.85-1.20)). Conclusions: We conclude that lifestyle factors may play a stronger role in the development of MetSyn in NW individuals compared with OB and that metabolically healthy obesity may not be a stable condition.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 41 条
  • [1] High adiponectin concentrations are associated with the metabolically healthy obese phenotype
    Aguilar-Salinas, Carlos A.
    Garcia Garcia, Eduardo
    Robles, Lorena
    Riano, Daniela
    Georgina Ruiz-Gomez, Doris
    Cristina Garcia-Ulloa, Ana
    Melgarejo, Marco A.
    Zamora, Margarita
    Guillen-Pineda, Luz E.
    Mehta, Roopa
    Canizales-Quinteros, Samuel
    Tusie Luna, Ma Teresa
    Gomez-Perez, Francisco J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) : 4075 - 4079
  • [2] Smoking combined with overweight or obesity markedly elevates cardiovascular risk factors
    Akbartabartoori, Mehdi
    Lean, Michael E. J.
    Hankey, Catherine R.
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (06): : 938 - 946
  • [3] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti, K. G. M. M.
    Eckel, Robert H.
    Grundy, Scott M.
    Zimmet, Paul Z.
    Cleeman, James I.
    Donato, Karen A.
    Fruchart, Jean-Charles
    James, W. Philip T.
    Loria, Catherine M.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
  • [4] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [5] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [6] 2-S
  • [7] BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
  • [8] Balkau B, 1999, DIABETIC MED, V16, P442
  • [9] "Sick Fat," Metabolic Disease, and Atherosclerosis
    Bays, Harold E.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (01) : S26 - S37
  • [10] American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome - 25-26 August 2002, Washington, DC
    Bloomgarden, ZT
    [J]. DIABETES CARE, 2003, 26 (04) : 1297 - 1303